retatrutide clinical trial weight loss results Lilly's delivers promising in Phase 3 : r/mounjarouk Effects of once-weekly subcutaneous retatrutide

Sunlight.com surveyed 1,200 GLP-1 users in September to learn about their spending habits since starting the drug

When a trusted clinician suggests a new drug, patients will give it a shot and theyll stay with it

In a Phase 2 trial published in the New England Journal of Medicine (2023), it demonstrated substantial weight loss in adults with obesity

The larger your target, the more meaningful the incremental advantage of tirzepatide or retatrutide becomes

You should not take Contrave if you: have uncontrolled high blood pressure have or have had seizures or an eating disorder like anorexia or bulimia are currently using opioid pain medications or are in opioid withdrawal take other medicines containing bupropion drink a lot of alcohol and suddenly stop have taken a monoamine oxidase inhibitor (MAOI) in the last 14 days You should use caution with Wegovy if you: have had problems with your pancreas or kidneys have type 2 diabetes and a history of diabetic retinopathy are taking insulin or other diabetes medications, as Wegovy can increase the risk of low blood sugar (hypoglycemia) Pregnancy and breastfeeding Neither drug is recommended during pregnancy, as weight loss offers no benefit to the fetus and may cause harm